New Frontiers in Therapy Selection: Beyond DNA Mutations
A NEW FRONTIERS SEMINAR | 11.05.25
This New Frontiers Seminar focused on the integration of multimodal data to inform and support therapy selection. The program highlighted emerging tools, such as RNA and epigenetic signatures, digital pathology, and more, and examines how they can be combined with liquid biopsy to capture real-time, multi-omic tumor dynamics. We also discussed the challenges and opportunities of bringing these next-generation approaches into clinical practice to expand access and advance personalized cancer care.
Be a part of the Discussion
Watch the entire seminar below.
View the Presentations
Read the White Paper
This New Frontiers Seminar white paper summarizes the presentations delivered during the seminar and highlights key insights from the panel discussion and Q&A session. We hope it provides a clear overview of current advances in multi-modal and AI-driven approaches to therapy selection, including applications in liquid biopsy and digital pathology.
